| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/27/2005 | US20050020629 Pain management |
| 01/27/2005 | US20050020625 Blocking starting compound with metal alkoxide; anticancer agents |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood |
| 01/27/2005 | US20050020597 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 01/27/2005 | US20050020594 Substituted pyridazinones |
| 01/27/2005 | US20050020588 Cysteine protease inhibitors |
| 01/27/2005 | US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050019281 Biphenyl-substituted triazines |
| 01/27/2005 | CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2531508A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | CA2496130A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500655A1 New methionine aminopeptidase inhibitor |
| 01/26/2005 | EP1500653A1 Substituted arylpyrazines |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections |
| 01/26/2005 | EP1499610A2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | EP1499594A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 01/26/2005 | EP1499593A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1399437B1 Method for the production of triazolylmethylepoxides |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1243579B1 Process for the production of pyridine derivatives |
| 01/26/2005 | EP1165091B1 Pharmaceutical emulsions for retroviral protease inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571786A Alkyl ether derivatives or salts thereof |
| 01/26/2005 | CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1570774A Organophotoreceptor with a charge transport compound having an epoxy group |
| 01/26/2005 | CN1569870A Nucleotide analogs with six-membered rings |
| 01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
| 01/26/2005 | CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846817 Nicotine receptor ligands |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2170637C Pyridazinone derivatives or their salts, processes for their production, and anti-shock agents containing them |
| 01/20/2005 | WO2005005418A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 01/20/2005 | WO2005005417A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005415A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | WO2005005414A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | WO2005005411A1 Substituted indole ligands for the orl-1 receptor |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005005395A2 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2005005393A2 Cck-1 receptor modulators |
| 01/20/2005 | WO2005004866A1 Therapeutic agents useful for treating pain |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2005004606A2 Pyridinylanilides |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | WO2004099124A3 Novel bioisosteres of actinonin |
| 01/20/2005 | WO2004096129A3 Inhibitors of akt activity |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069792A3 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014954 Pyrrole synthesis |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014909 Cured thermosetting resin |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014818 Process for producing optically active chroman derivative and intermediate |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014814 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014773 Therapeutic use |
| 01/20/2005 | US20050014769 Anticancer agents; controlling apoptosis |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014750 Isochroman compounds for treatment of cns disorders |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |